Replies to post #17484 on GlobeStar Therapeutics Corp (GSTC)

[Aquahoya]

Just found this an interesting comparable. Obviously, we are in the OTC, but if and when we get approval, no reason we don't see and hold a solid pps around .09/.10. Little liabilities in comparison to this other company going through phase MS trials amongst other things.

$GSTC Just saw IMUX with an $80 million MC, sitting at $1.79 (as high as $10-12, $28) with a 35-40 mill OS during phase 2 trials for MS drug. It has $85 mill in debt. Received $60 mill in funding. GSTC will have no debt and 10s of millions of funding from NY Bay. Looks good. pic.twitter.com/VBnb085QfX

— Kevin C (@Aquahoya) January 20, 2023